首页|一种多重修饰血紫蛋白纳米氧载体的构建及体外性能检测

一种多重修饰血紫蛋白纳米氧载体的构建及体外性能检测

扫码查看
背景:血紫蛋白分子稳定性及生物相容性优于人和哺乳动物血红蛋白,经过修饰可能成为更加安全长效的红细胞代用品.目的:制备多重修饰血紫蛋白纳米微粒,进行理化性质表征及体外性能测试.方法:以切向流超滤法分离纯化方格星虫血紫蛋白,使用京尼平完成分子内交联,然后利用多巴胺完成纳米粒子封装,再用聚乙二醇完成钝化,获得多重修饰血紫蛋白纳米粒,表征该纳米粒的理化性质.将不同质量浓度(0,0.25,0.5,1.0,2.0 mg/mL)的血紫蛋白纳米粒、血紫蛋白、血红蛋白氧载体HBOC-201分别与巨噬细胞共同孵育6,24 h,与血管内皮细胞共同孵育24 h,采用CCK-8法检测细胞存活率,ELISA法检测血管内皮细胞培养液中一氧化氮及血管细胞黏附因子1水平.结果与结论:①血紫蛋白纳米粒电镜下呈现椭球形,有致密外膜,内部质地较为均匀,粒径为(150.12±1.67)nm,分散指数为0.21±0.03,Zeta电位为(-24.54±2.61)mV,半饱和氧分压为(0.97±0.15)kPa,Hill系数为1.49±0.16.②孵育6 h,在≤1.0 mg/mL质量浓度范围内,血紫蛋白纳米粒组、血紫蛋白组、HBOC-201组巨噬细胞存活率均在85%以上;在2.0 mg/mL质量浓度下,仅血紫蛋白纳米粒组巨噬细胞存活率在80%以上.孵育24 h,3组巨噬细胞存活率均低于80%,其中血紫蛋白纳米粒组巨噬细胞存活率高于血紫蛋白组、HBOC-201组(P<0.05).③随着药物质量浓度的增加,3组血管内皮细胞存活率降低,在1.0 mg/mL或2.0 mg/mL质量浓度下,血紫蛋白纳米粒组细胞存活率高于血紫蛋白组、HBOC-201组(P<0.05);在相同质量浓度下,血紫蛋白纳米粒组一氧化氮水平高于血紫蛋白组、HBOC-201组(P<0.05);在0.25-2.0 mg/mL质量浓度范围内,血紫蛋白纳米粒组血管细胞黏附因子1水平低于血紫蛋白组、HBOC-201组(P<0.05).④结果表明,经过分子内交联和聚多巴胺/聚乙二醇修饰的血紫蛋白纳米粒在体外具有良好的携氧活性,抗吞噬性能更优,细胞毒性更小.
Construction and in vitro performance testing of a multi-modified hemerythrin-based nano-oxygen carrier
BACKGROUND:Molecular stability and biocompatibility of hemerythrin surpass those of human and mammalian hemoglobin,making it a potential candidate for a safer and more effective erythrocyte substitute after modification.OBJECTIVE:To prepare multi-modified hemerythrin nanoparticles,characterize them,and test their performance in vitro.METHODS:The hemerythrin of Sipunculus sphenodontus was separated and purified by tangential flow ultrafiltration.The intramolecular cross-linking was completed by genipin.The nanoparticles were encapsulated by dopamine,and passivated by polyethylene glycol to obtain multi-modified hemerythrin nanoparticles.The physicochemical properties of the nanoparticles were characterized.Hemerythrin nanoparticles,hemerythrin,and hemoglobin oxygen carrier HBOC-201 with different mass concentrations(0,0.25,0.5,1.0,and 2.0 mg/mL)were incubated with macrophages for 6 and 24 hours,and with endothelial cells for 24 hours.The cell survival rate was detected by CCK-8 assay.The levels of nitric oxide and vascular cell adhesion factor 1 in the culture medium of endothelial cells were detected by ELISA.RESULTS AND CONCLUSION:(1)Under electron microscopy,hemerythrin nanoparticles were ellipsoidal,with a dense outer membrane and a relatively uniform internal texture.The particle size was(150.12±1.67)nm;the dispersion index was 0.21±0.03;the Zeta potential was(-24.54±2.61)mV;the half-saturated oxygen partial pressure was(0.97±0.15)kPa,and the Hill coefficient was 1.49±0.16.(2)After incubation for 6 hours,within the mass concentration range of≤1.0 mg/mL,the survival rates of macrophages in the hemerythrin nanoparticle group,the hemerythrin group,and the HBOC-201 group were all above 85%.At a mass concentration of 2.0 mg/mL,only the survival rate of macrophages in the hemerythrin nanoparticle group was above 80%.After incubation for 24 hours,the survival rates of macrophages in the three groups were all lower than 80%,among which the survival rate of macrophages in the hemerythrin nanoparticle group was higher than that in the hemerythrin group and the HBOC-201 group(P<0.05).(3)With the increase of drug concentration,the survival rate of vascular endothelial cells in the three groups decreased.At 1.0 mg/mL or 2.0 mg/mL mass concentration,the survival rate of cells in the hemerythrin nanoparticle group was higher than that in the hemerythrin group and HBOC-201 group(P<0.05).At the same mass concentration,the nitric oxide level in the hemerythrin nanoparticle group was higher than that in the hemerythrin group and HBOC-201 group(P<0.05).In the range of 0.25-2.0 mg/mL mass concentration,the vascular cell adhesion factor 1 level in the hemerythrin nanoparticle group was lower than that in the hemerythrin group and HBOC-201 group(P<0.05).(4)The results showed that the hemerythrin nanoparticles modified with intramolecular cross-linking and polydopamine/polyethylene glycol had good oxygen-carrying activity in vitro,better anti-phagocytic performance,and less cytotoxicity.

erythrocyte substituteshemerythrinchemical modificationcell experimentshemoglobin-based oxygen carriers

黄志华、赵会民、苏春元、杨康

展开 >

广西医科大学第二附属医院 急诊科,广西壮族自治区 南宁市 530007

广西医科大学第二附属医院 创伤中心,广西壮族自治区 南宁市 530007

广西地中海贫血防治重点实验室,广西壮族自治区 南宁市 530007

广西重点急危重症医学实验室,广西壮族自治区 南宁市 530007

展开 >

红细胞代用品 血紫蛋白 化学修饰 细胞实验 血红蛋白氧载体

2025

中国组织工程研究
中国康复医学会,《中国组织工程研究与临床康复》杂志社

中国组织工程研究

北大核心
影响因子:1.387
ISSN:2095-4344
年,卷(期):2025.29(22)